Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial

AIMS: To elucidate the effects of intensive LDL-C lowering treatment with a standard dose of statin and ezetimibe in patients with dyslipidaemia and high risk of coronary events, targeting LDL-C less than 70 mg/dL (1.8 mmol/L), compared with standard LDL-C lowering lipid monotherapy targeting less t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur Heart J
Asıl Yazarlar: Hagiwara, Nobuhisa, Kawada-Watanabe, Erisa, Koyanagi, Ryo, Arashi, Hiroyuki, Yamaguchi, Junichi, Nakao, Koichi, Tobaru, Tetsuya, Tanaka, Hiroyuki, Oka, Toshiaki, Endoh, Yasuhiro, Saito, Katsumi, Uchida, Tatsuro, Matsui, Kunihiko, Ogawa, Hiroshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837267/
https://ncbi.nlm.nih.gov/pubmed/28430910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehx162
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller